{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:26:35Z","timestamp":1767979595868,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T00:00:00Z","timestamp":1506902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T00:00:00Z","timestamp":1506902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12672-017-0309-2","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T15:17:48Z","timestamp":1506957468000},"page":"298-313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Expression of Genes for Methylxanthine Pathway-Associated Enzymes Accompanied by Sex Steroid Receptor Status Impacts Breast Carcinoma Progression"],"prefix":"10.1007","volume":"8","author":[{"given":"James L.","family":"Wittliff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth B.","family":"Sereff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"issue":"2","key":"309_CR1","doi-asserted-by":"publisher","first-page":"e1001961: 1","DOI":"10.1371\/journal.pmed.1001961","volume":"13","author":"R Natrajan","year":"2016","unstructured":"Natrajan R et al (2016) Microenvironmental heterogeneity parallels breast cancer progression: a histology-genomic integration analysis. PLoS Med 13(2):e1001961: 1\u2013e1001961:19","journal-title":"PLoS Med"},{"issue":"3","key":"309_CR2","doi-asserted-by":"publisher","first-page":"e90907","DOI":"10.1371\/journal.pone.0090907","volume":"9","author":"MM Al-Ansari","year":"2014","unstructured":"Al-Ansari MM, Aboussekhra A (2014) Caffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genes. PLoS One 9(3):e90907","journal-title":"PLoS One"},{"issue":"7\u20139","key":"309_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1387\/ijdb.113362aa","volume":"55","author":"A Aboussekhra","year":"2011","unstructured":"Aboussekhra A (2011) Role of cancer-associated fibroblasts in breast cancer development and prognosis. Int J Dev Biol 55(7\u20139):841\u2013849","journal-title":"Int J Dev Biol"},{"issue":"7","key":"309_CR4","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/bjc.2014.69","volume":"110","author":"CL Downey","year":"2014","unstructured":"Downey CL et al (2014) The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer. Br J Cancer 110(7):1744\u20131747","journal-title":"Br J Cancer"},{"issue":"1","key":"309_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcdb.2009.10.010","volume":"21","author":"OE Franco","year":"2010","unstructured":"Franco OE et al (2010) Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 21(1):33\u201339","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"309_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 121(3):335\u2013348","journal-title":"Cell"},{"issue":"2","key":"309_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrc2067","volume":"7","author":"A Albini","year":"2007","unstructured":"Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7(2):139\u2013147","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"309_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10549-013-2571-5","volume":"139","author":"TJ Dekker","year":"2013","unstructured":"Dekker TJ et al (2013) Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat 139(2):371\u2013379","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"309_CR9","first-page":"465","volume":"39","author":"S Miwa","year":"2011","unstructured":"Miwa S et al (2011) Caffeine activates tumor suppressor PTEN in sarcoma cells. Int J Oncol 39(2):465\u2013472","journal-title":"Int J Oncol"},{"issue":"5","key":"309_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/bjc.2015.276","volume":"113","author":"M Hashibe","year":"2015","unstructured":"Hashibe M et al (2015) Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. Br J Cancer 113(5):809\u2013816","journal-title":"Br J Cancer"},{"issue":"8","key":"309_CR11","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/ijc.29569","volume":"137","author":"JK Oh","year":"2015","unstructured":"Oh JK et al (2015) Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. Int J Cancer 137(8):1979\u20131989","journal-title":"Int J Cancer"},{"issue":"3","key":"309_CR12","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ygyno.2013.03.014","volume":"129","author":"W Jiang","year":"2013","unstructured":"Jiang W, Wu Y, Jiang X (2013) Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Gynecol Oncol 129(3):620\u2013629","journal-title":"Gynecol Oncol"},{"issue":"7","key":"309_CR13","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1017\/S1368980011000371","volume":"14","author":"G Fagherazzi","year":"2011","unstructured":"Fagherazzi G et al (2011) No association between coffee, tea or caffeine consumption and breast cancer risk in a prospective cohort study. Public Health Nutr 14(7):1315\u20131320","journal-title":"Public Health Nutr"},{"issue":"5","key":"309_CR14","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1055-9965.EPI-06-1074","volume":"16","author":"J Kotsopoulos","year":"2007","unstructured":"Kotsopoulos J et al (2007) The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomark Prev 16(5):912\u2013916","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"309_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1158\/1055-9965.EPI-07-0555","volume":"17","author":"E Bageman","year":"2008","unstructured":"Bageman E et al (2008) Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomark Prev 17(4):895\u2013901","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"309_CR16","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1158\/1078-0432.CCR-14-1748","volume":"21","author":"AH Rosendahl","year":"2015","unstructured":"Rosendahl AH et al (2015) Caffeine and caffeic acid inhibit growth and modify estrogen receptor and insulin-like growth factor I receptor levels in human breast cancer. Clin Cancer Res 21(8):1877\u20131887","journal-title":"Clin Cancer Res"},{"issue":"9","key":"309_CR17","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/ijc.23336","volume":"122","author":"D Ganmaa","year":"2008","unstructured":"Ganmaa D et al (2008) Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122(9):2071\u20132076","journal-title":"Int J Cancer"},{"issue":"2","key":"309_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s12020-011-9522-x","volume":"40","author":"SA Andres","year":"2011","unstructured":"Andres SA, Wittliff JL (2011) Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue. Endocrine 40(2):212\u2013221","journal-title":"Endocrine"},{"key":"309_CR19","first-page":"463","volume-title":"Techniques in confocal microscopy","author":"JL Wittliff","year":"2010","unstructured":"Wittliff JL (2010) Laser capture microdissection and its use in genomics & proteomics, in reliable lab solutions. In: Conn PM (ed) Techniques in confocal microscopy. Elsevier Press, Amsterdam, pp 463\u2013477"},{"issue":"10","key":"309_CR20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883\u2013892","journal-title":"N Engl J Med"},{"issue":"2","key":"309_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10549-006-9242-8","volume":"100","author":"LM McShane","year":"2006","unstructured":"McShane LM et al (2006) Reporting recommendations for tumor marker prognostic studies (REMARK). Breast Cancer Res Treat 100(2):229\u2013235","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"309_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12672-011-0080-8","volume":"2","author":"DA Kerr 2nd","year":"2011","unstructured":"Kerr DA 2nd, Wittliff JL (2011) A five-gene model predicts clinical outcome in ER+\/PR+, early-stage breast cancers treated with adjuvant tamoxifen. Horm Cancer 2(5):261\u2013271","journal-title":"Horm Cancer"},{"issue":"3","key":"309_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-015-3507-z","volume":"152","author":"SA Andres","year":"2015","unstructured":"Andres SA et al (2015) Interaction between smoking history and gene expression levels impacts survival of breast cancer patients. Breast Cancer Res Treat 152(3):545\u2013556","journal-title":"Breast Cancer Res Treat"},{"issue":"16\u201317","key":"309_CR24","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.clinbiochem.2013.07.005","volume":"46","author":"TL Kruer","year":"2013","unstructured":"Kruer TL et al (2013) Characterization of estrogen response element binding proteins as biomarkers of breast cancer behavior. Clin Biochem 46(16\u201317):1739\u20131746","journal-title":"Clin Biochem"},{"issue":"2","key":"309_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10549-016-4049-8","volume":"161","author":"MW Daniels","year":"2017","unstructured":"Daniels MW, Brock GN, Wittliff JL (2017) Clinical outcomes linked to expression of gene subsets for protein hormones and their cognate receptors from LCM-procured breast carcinoma cells. Breast Cancer Res Treat 161(2):245\u2013258","journal-title":"Breast Cancer Res Treat"},{"key":"309_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/1471-2407-13-326","volume":"13","author":"SA Andres","year":"2013","unstructured":"Andres SA, Brock GN, Wittliff JL (2013) Interrogating differences in expression of targeted gene sets to predict breast cancer outcome. BMC Cancer 13:326\u2013344","journal-title":"BMC Cancer"},{"issue":"1","key":"309_CR27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1515\/hmbci-2012-0025","volume":"12","author":"SA Andres","year":"2012","unstructured":"Andres SA, Wittliff JL (2012) Co-expression of genes with estrogen receptor-alpha and progesterone receptor in human breast carcinoma tissue. Horm Mol Biol Clin Investig 12(1):377\u2013390","journal-title":"Horm Mol Biol Clin Investig"},{"key":"309_CR28","first-page":"S15","volume-title":"Breast cancer research and treatment: 2003","author":"X Ma","year":"2003","unstructured":"Ma X et al (2003) Gene expression signatures associated with clinical outcome in breast cancer via laser capture microdissection. In: Breast cancer research and treatment: 2003. Kluwer Academic Publ, Dordrecht, pp S15\u2013S15"},{"issue":"10","key":"309_CR29","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1073\/pnas.0931261100","volume":"100","author":"XJ Ma","year":"2003","unstructured":"Ma XJ et al (2003) Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 100(10):5974\u20135979","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"309_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10549-015-3445-9","volume":"152","author":"H Dong","year":"2015","unstructured":"Dong H et al (2015) Inhibition of breast cancer cell migration by activation of cAMP signaling. Breast Cancer Res Treat 152(1):17\u201328","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl 1","key":"309_CR31","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JAD-2010-1379","volume":"20","author":"JA Ribeiro","year":"2010","unstructured":"Ribeiro JA, Sebastiao AM (2010) Caffeine and adenosine. J Alzheimers Dis 20(Suppl 1):S3\u201315","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"309_CR32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/FPC.0b013e3283505d5e","volume":"22","author":"CF Thorn","year":"2012","unstructured":"Thorn CF et al (2012) PharmGKB summary: caffeine pathway. Pharmacogenet Genomics 22(5):389\u2013395","journal-title":"Pharmacogenet Genomics"},{"issue":"4","key":"309_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/clpt.2012.96","volume":"92","author":"M Whirl-Carrillo","year":"2012","unstructured":"Whirl-Carrillo M et al (2012) Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther 92(4):414\u2013417","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"309_CR34","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1158\/1078-0432.CCR-15-1900","volume":"22","author":"S Catalano","year":"2016","unstructured":"Catalano S et al (2016) Expression and function of phosphodiesterase type 5 in human breast cancer cell lines and tissues: implications for targeted therapy. Clin Cancer Res 22(9):2271\u20132282","journal-title":"Clin Cancer Res"},{"key":"309_CR35","unstructured":"Fleisher M et al (2002) Practice guidelines and recommendations for use of tumor markers in the clinic. In: Tumor markers: physiology, pathobiology, technology and clinical applications, D. P. Diamandis, H. A. Fritsche, H. Lilja, D. W. Chan, M. K. Schwartz (eds.), AACC Press, Washington, D.C, p 33\u201363"},{"key":"309_CR36","unstructured":"Wittliff J, Pasic R, Bland K (1998) Steroid and peptide hormone receptors: methods, quality control and clinical use. In: The breast: comprehensive management of benign and malignant diseases, K. I. Bland and E. M. Copeland III (eds.), WB Saunders Co, Philadelphia, Chapter 25, p 458\u2013498"},{"issue":"6","key":"309_CR37","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/jcla.1860040608","volume":"4","author":"R Pasic","year":"1990","unstructured":"Pasic R, Djulbegovic B, Wittliff JL (1990) Comparison of sex steroid receptor determinations in human breast cancer by enzyme immunoassay and radioligand binding. J Clin Lab Anal 4(6):430\u2013436","journal-title":"J Clin Lab Anal"},{"key":"309_CR38","unstructured":"Therneau T (2013) A package for survival analysis in S. R package version 2.37\u20134. Box 980032:23298\u20130032, URL http:\/\/cran.R-project.org\/package=survival"},{"issue":"6","key":"309_CR39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.5858\/134.6.907","volume":"134","author":"ME Hammond","year":"2010","unstructured":"Hammond ME et al (2010) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134(6):907\u2013922","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"309_CR40","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.jclinepi.2004.04.003","volume":"57","author":"PC Austin","year":"2004","unstructured":"Austin PC, Tu JV (2004) Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol 57(11):1138\u20131146","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"309_CR41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/bimj.200900028","volume":"52","author":"JJ Goeman","year":"2010","unstructured":"Goeman JJ (2010) L1 Penalized estimation in the cox proportional hazards model. Biom J 52(1):70\u201384","journal-title":"Biom J"},{"key":"309_CR42","unstructured":"Goeman JJ, et al.(2016) L1 and L2 penalized regression models. R Studio Version 0.9-47"},{"issue":"5","key":"309_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon N et al (2011) Regularization paths for Cox\u2019s proportional hazards model via coordinate descent. J Stat Softw 39(5):1\u201313","journal-title":"J Stat Softw"},{"issue":"1","key":"309_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33(1):1\u201322","journal-title":"J Stat Softw"},{"issue":"9","key":"309_CR45","doi-asserted-by":"publisher","first-page":"e74250: 1","DOI":"10.1371\/journal.pone.0074250","volume":"8","author":"R Aguirre-Gamboa","year":"2013","unstructured":"Aguirre-Gamboa R et al (2013) SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PLoS One 8(9):e74250: 1\u2013e74250: 9","journal-title":"PLoS One"},{"issue":"2","key":"309_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/bjc.1970.25","volume":"24","author":"P Stocks","year":"1970","unstructured":"Stocks P (1970) Cancer mortality in relation to national consumption of cigarettes, solid fuel, tea and coffee. Br J Cancer 24(2):215\u2013225","journal-title":"Br J Cancer"},{"issue":"3","key":"309_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","volume":"100","author":"K Omori","year":"2007","unstructured":"Omori K, Kotera J (2007) Overview of PDEs and their regulation. Circ Res 100(3):309\u2013327","journal-title":"Circ Res"},{"issue":"305","key":"309_CR48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1126\/scitranslmed.aac5125","volume":"7","author":"TM Burke","year":"2015","unstructured":"Burke TM et al (2015) Effects of caffeine on the human circadian clock in vivo and in vitro. Sci Transl Med 7(305):146\u2013165","journal-title":"Sci Transl Med"},{"issue":"52","key":"309_CR49","doi-asserted-by":"crossref","first-page":"87232","DOI":"10.18632\/oncotarget.13601","volume":"7","author":"W Wang","year":"2016","unstructured":"Wang W et al (2016) Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition. Oncotarget 7(52):87232\u201387245","journal-title":"Oncotarget"},{"issue":"6","key":"309_CR50","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/bcr3574","volume":"15","author":"T Leung","year":"2013","unstructured":"Leung T et al (2013) Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells. Breast Cancer Res 15(6):R107\u2013R118","journal-title":"Breast Cancer Res"},{"issue":"1","key":"309_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198107023050101","volume":"305","author":"B Fisher","year":"1981","unstructured":"Fisher B et al (1981) Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med 305(1):1\u20136","journal-title":"N Engl J Med"},{"issue":"4","key":"309_CR52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1200\/JCO.1983.1.4.227","volume":"1","author":"B Fisher","year":"1983","unstructured":"Fisher B et al (1983) Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. J Clin Oncol 1(4):227\u2013241","journal-title":"J Clin Oncol"},{"issue":"31","key":"309_CR53","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC et al (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31(31):3997\u20134013","journal-title":"J Clin Oncol"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-017-0309-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-017-0309-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-017-0309-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T12:36:41Z","timestamp":1719491801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-017-0309-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":53,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1007\/s12672-017-0309-2","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,2]]},"assertion":[{"value":"28 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}